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The relationship between azaspiracid shellfish poisoning and a small dinoflagellate, Azadinium 
spinosum, has been shown recently. The organism produces AZA1 and -2, while AZA3 and 
other analogues are metabolic products formed in shellfish. We evaluated whether mussels were 
capable of accumulating dissolved AZA1 and -2, and compared the toxin profiles of these 
mussels at 24 h with profiles of those exposed to live or lysed A. spinosum. We also assessed 
the possibility of preparative production of AZA metabolites by exposing mussels to semi-
purified AZA1. 
We exposed mussels to similar concentration of AZAs: dissolved AZA1+2 (crude extract) at 
7.5 and 0.75 µg L
-1
, dissolved AZA1+2 (7.5 µg L
-1
) in combination with Isochrysis affinis 
galbana, and lysed and live A. spinosum cells at 1 × 10
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we dissected and analysed digestive glands, gills and remaining flesh. Mussels (whole flesh) 
accumulated AZAs above the regulatory limit except at the lower levels of dissolved AZAs. 
The toxin profile of the mussels varied significantly with treatment. The gills contained 42–46% 
and the digestive glands 23–24% of the total toxin load using dissolved AZAs, compared to 3–
12% and 75–90%, respectively, in mussels exposed to live A. spinosum. Exposure of mussels to 
semi-purified AZA1 produced the metabolites AZA17 (16.5%) and AZA3 (1.7%) after 4 days 
of exposure, but the conversion efficiency was too low to justify using this procedure for 
preparative isolation. 
Key words 
Dissolved marine biotoxins, AZA, tissue distribution, bivalve molluscs, LC-MS/MS, 
azaspiracid, metabolism, mussel 
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1. Introduction  
Azaspiracid shellfish poisoning (AZP) occurred for the first time in the Netherlands in 
November 1995. Contaminated mussels (Mytilus edulis) cultivated in Ireland (Killary Harbour) 
were consumed and intoxicated at least eight people (McMahon and Silke, 1996). Three years 
later the implicated toxin was identified, isolated, structurally defined and named azaspiracid 
(now called azaspiracid-1 (AZA1)) due to its unique spiro ring assembly (Satake et al., 1998). 
The structure has since been corrected following its chemical synthesis (Nicolaou et al., 2006). 
AZAs in aquatic organisms have been found in Europe, Africa and more recently in the 
Americas and Japan (Alvarez et al., 2010; Amzil et al., 2008; Furey et al., 2010; Klontz et al., 
2009; Magdalena et al., 2003; Taleb et al., 2006; Twiner et al., 2008; Ueoka et al., 2009), 
indicating a worldwide phenomenon. More than 30 AZA analogs have been reported (Rehmann 
et al., 2008). Of these, only AZA1 and -2 were actually found in the primary producer (Krock et 
al., 2009) recently isolated and named A. spinosum (Krock et al., 2008; Krock et al., 2009; 
Tillmann et al., 2009). A. spinosum is a small dinoflagellate (12–16 µm length and 7–11 µm 
width), originally isolated in the North Sea near the Scottish coast (Tillmann et al., 2009). 
Following its description, another A. spinosum was isolated in Ireland (Salas et al., 2011), and 
Azadinium obesum (not known to produce AZAs, North Sea) (Tillmann et al., 2010), and 
Azadinium poporum (North Sea) and Azadinium cf. poporum (Korean coast) (Potvin et al., 
2012; Tillmann et al., 2011) were isolated and characterised. The last two species were recently 
found to produce new AZAs, also observed in Amphidoma languida, a species close to 
Azadinium spp. in the phylogeny (Krock et al., 2012; Tillmann et al., 2012). A. cf. spinosum has 





) in 1990, although no data on AZAs or reports of intoxications were reported 
(Akselman and Negri, 2012). 
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Since its discovery, the North Sea strain of A. spinosum has been cultured for toxin production 
in pilot-scale photobioreactors (Jauffrais et al., 2012b). However, while the organism produces 
AZA1 and -2, it does not produce the metabolites formed in shellfish (AZA3 to -23, reviewed in 
Rehmann et al. (2008)) (Krock et al., 2009; McCarron et al., 2009). The first demonstration of 
AZA accumulation in mussels after controlled exposure to A. spinosum showed rapid 
biotransformation of AZA1 to AZA17 (Salas et al., 2011). This fast biotransformation was 
subsequently confirmed in a larger scale experiment, where AZA17 and -19 were identified as 
major metabolites that should be regulated in uncooked mussels (Jauffrais et al., 2012c). As 
after cooking, AZA17 and -19 are biotransformed into AZA3 and -6, respectively (McCarron et 
al., 2009); two AZAs known to be toxic. AZA3 has an AZA1 toxic equivalent factor (TEF) of 
1.4 (Ofuji et al., 1999) and concerning the relative in vitro potency of AZA6, it appears to be 
not unlike that of AZA1 (Dr. M. Twiner, personal communication). No purified AZA17 and -19 
are currently available for use as analytical standards, however, nor is there a sustainable way of 
producing AZA3, an already regulated degradation product of AZA17, other than by complex 
organic synthesis (Perez et al., 2010) or isolation from contaminated mussels (Kilcoyne et al., 
2012; Perez et al., 2010). 
A major ecological question is also the bioavailability of dissolved marine biotoxins to marine 
organisms. Effectively, when harmful algal blooms degrade, they release toxins into the 
dissolved phase (surrounding water). Studies have been carried out to evaluate toxin 
accumulation or effects of dissolved toxins on early stages of development of aquatic organisms 
(Colman et al., 2005; Korpinen et al., 2006; Lefebvre et al., 2005; Liu et al., 2007) on 
planktonic species (Babica et al., 2007; Bargu et al., 2006) and on adult fish (Bakke and 
Horsberg, 2010; Cazenave et al., 2005). However, very little is known about the ability of 
bivalve molluscs to accumulate dissolved marine biotoxins (Liu et al., 2007; Novaczek et al., 
1991; Plakas et al., 2002). 
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Dissolved AZAs, found in waters on the Irish and Norwegian coasts, raises questions on the 
ability of mussels to accumulate dissolved AZAs in situ (Fux et al., 2009; Rundberget et al., 
2009). Transplanted mussels (free of AZAs) followed the same kinetics of uptake as SPATT 
(solid phase adsorption toxin tracking) discs, but cross contamination by A. spinosum cells 
cannot be excluded (Fux et al., 2009). Furthermore, a recent study (O'Driscoll et al., 2011) on 
AZA1 biotransformation by mussels showed the ability of mussels to accumulate dissolved 
AZA1 when co-administered with a commercial bivalve. However, the authors only focused on 
biotransformation pathways and did not quantify the concentrations of AZAs accumulated in 
the mussel tissues. 
The present study explored the ability of mussels to accumulate dissolved AZAs and the effect 
of route of administration on toxin profiles site of AZAs accumulation in mussels. A second 
trial was performed to assess whether this procedure could be used for preparative isolation of 
metabolites when mussels were also exposed to a high concentration of dissolved AZA1. 
2. Material and methods 
2.1. Collection and maintenance of bivalves 
Trial A. Blue mussels were collected from the West coast of France (Ré Island) in April 2012, a 
place at that time known to be free of known marine phycotoxins. Mussels were transported to 
the aquarium facilities, washed, and cleaned of remaining epibionts. They were placed in two 
20 L aerated aquaria, filled with sea water (35 psu) and maintained at ±16 °C (room 
temperature). The mussels were unfed for 5 days prior to the experiment to clean their digestive 
tract of all lingering food. Their average length (44 ± 3 mm) was above commercial size, with a 
wet-flesh weight of 1.9 ± 0.2 g. Digestive glands accounted for 25.5%, gills 11.7% and 
remaining flesh 62.8% of the total mussel weight.  
Trial B. Blue mussels were obtained from Kelly Shellfish, Kilcolgan, Ireland, in November 
2011, at that time known to be free of known marine phycotoxins. They were washed, cleaned 
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of remaining epibionts, and placed in 10 L aquaria containing filtered (0.2 µm) and aerated 
seawater. Mussels were above commercial size, sea water was changed daily, and mussels were 
fed a commercial diet for bivalves containing Isochrysis, Pavlova, Tetraselmis and 
Thalassiosira weissflogii (Shellfish diet 1800, Reed Mariculture, Cambell, USA). 
2.2. Phytoplankton 
A. spinosum strain 3D9 was used to study accumulation of AZA1 and -2 in mussels. The alga 
was grown in a stirred photobioreactor (100 L) operated in chemostat mode at a dilution rate 
of 0.2 day
-1
 under the environmental conditions of Jauffrais et al. (2012b). 
Isochrysis aff. galbana (CCAP 927/14, T-Iso) was grown in 10 L batch culture under the 
same conditions as for A. spinosum, but in F/2 medium (Guillard, 1975; Guillard and Ryther, 
1962). Cell concentrations (cell.mL
-1
) were determined using a particle counter (Multisizer 3 
Coulter counter, Beckman) and assessed 6 times in the different conditions using A. spinosum 
and T-Iso. 
2.3. Preparation of crude and semi-purified toxin extracts 
Crude extract of A. spinosum was used as dissolved AZA1 and -2. A 200 L culture of A. 
spinosum was maintained in an aerated 300 L transparent cylindroconical tank after 
production in two 100 L stirred photobioreactors at a flow rate of 0.2 day
-1
. Biomass (200 L) 
was collected by tangential flow filtration, followed by adsorption of AZAs onto activated 
HP-20 Diaion resin (25 g) from the sonicated algal concentrate (± 1 L). The washed resin was 
placed in a glass column and eluted with acetone (3 × 50 mL), and the eluate evaporated and 
reconstituted in 10 mL of methanol (Jauffrais et al., 2012b). This crude algal extract contained 
110 ± 6 µg.mL
-1
 of AZA1 plus AZA2 (ratio 79:21). Aliquots (541 or 54 μL) of this solution 
were added to 8 L of sea water in trial A. 
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Semi-purified AZA1 was obtained from mussel tissue (M. edulis) collected in 2005 from 
Bruckless, Donegal, Ireland following the 6
th
 step of  a 7 step isolation procedure as described 
in Kilcoyne et al. (2012), and used in trial B. 
2.4. Experimental design 
Trial A. After acclimatisation to the laboratory conditions, 120 mussels were distributed in 10 L 
aerated flat-bottomed glass flasks (5 per flask) with 8 L of sea water. Each treatment was 
performed in triplicate and the mussels were exposed to the conditions presented in table 1. 
Aliquots (541 or 54 μL) of crude extract were added to 8 L of sea water with (treatement 1 







) in a bioreactor at steady state with a cell quota of 
75.4 ± 0.8 fg.cell
-1
 AZA1 plus AZA2 (ratio 76:24). The required concentrations were obtained 
by dilution with sea water (treatement 4 and 6). For treatments 5 and 7, the culture (A. 
spinosum) was sonicated (pulse mode, 30 min in ice, maximum amplitude, Bioblock Scientific, 
Vibra-cell 75115), and a sample was checked to ensure total cellular lysis. 
Trial B: Acclimatized mussels (3) were transferred to a 5 L conical flask containing 3 L of 
filtered seawater, to which Shellfish diet 1800 (100 µL) and 100 µL of semi-purified AZA1 
solution were added, to give a final AZA1 concentration of 33 µg L
-1
. 
2.5. AZA analysis  
2.5.1. Reagents  
Certified reference materials (CRMs) of AZA1, -2 and -3 were from the NRC, Certified 
Reference Material Program (Halifax, NS, Canada). Ammonium formate (reagent grade) and 
formic acid were from Sigma–Aldrich (Steinheim, Germany). 
Trial A: Acetone and methanol (HPLC grade) were from JT Baker. Milli-Q water for the 
HPLC mobile phase was supplied by a Milli-Q integral 3 system (Millipore).  
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Trial B: All solvents (pestican grade) were from Labscan (Dublin, Ireland).  
2.5.2. AZA extraction from A. spinosum 
Triplicate samples of A. spinosum culture were taken from the harvesting tank prior to mussel 
exposure and extracted according to Jauffrais et al. (2012a). Briefly, aliquots (10 mL) of A. 
spinosum cultures were collected and centrifuged (2500 g, 4 °C, 20 min). The pellet was re-
suspended in acetone–H2O (0.5 mL, 9:1, v/v), transferred to an Eppendorf tube, sonicated and 
centrifuged. The supernatant was transferred to a 5 mL glass tube and gently evaporated under 
nitrogen (35 °C). The pellet was re-extracted twice more in the same manner. the combined 
extracts evaporated, and the residue reconstituted in methanol (1 mL), filtered, and analyzed 
by LC-MS/MS (method A). 
2.5.3. AZA extraction from Mussel tissues 
Trial A: The extraction procedure was adapted from Villar-Gonzalez et al. (2011) as detailed in 
Jauffrais et al. (2012c). At the end of the exposure, mussels were opened to allow mantle fluid 
to drain, gills were carefully dissected with scissors, the digestive gland was separated from 
the mussel tissues, and the remaining flesh was detached from the shell. The 3 different 
tissues from the five mussels of each flask were drained for 5 min, placed in a 50 mL 
centrifuge tube and weighed to measure wet weight, then stored at −80 °C until extraction. 
Prior to extraction, the tissues were thawed, methanol (9 mL) was added, and samples were 
extracted using a high-speed homogenizer (Polytron PT1300D) at 15 000 rpm for 5 min. 
Samples were centrifuged at 4500 g for 5 min at 4 °C, and the supernatants transferred to 20 mL 
volumetric flasks. Another 9 mL of methanol was added to the remaining pellet and 
homogenized again. Centrifugation was repeated as above, and supernatants were transferred to 
the same 20 mL volumetric flasks. Volumetric flasks were then made up to the mark using 
methanol, extracts were filtered (Nonosep MF 0.2 µm centrifugal filter), and analyzed by LC-
MS/MS (method A). 
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Trial B: After exposure, mussels were removed from the tank, opened to allow mantle fluid to 
drain, shucked and weighed. The mussel tissue was transferred to a Waring blender and 
homogenized for 1 min. Homogenized tissue (1.0 g) was extracted twice (Ultra turrax, IKA-
Werke T25 at 11 000 rpm) for 1 min with methanol (2 × 9 mL). Extracts were centrifuged 
(3 950 g, 5 min) and the supernatants decanted into 25 mL volumetric flasks which were 
brought to volume with methanol. Samples were filtered (Millipore PVDF, 0.45µm ) prior to 
analysis by LC-MS/MS (method B). 
2.5.4. AZA extraction from sea water  
Solid phase extraction (SPE) cartridges (Oasis HLB, 3 cc, 100 mg) were activated with 
methanol (5 mL) and washed with a solution of water–methanol (9:1 v/v, 3 mL). The sample 
(5 mL) was then loaded dropwise, the cartridge washed with water–methanol (9:1 v/v, 5 mL), 
and the sample eluted with methanol (5 mL) into a glass tube for analysis by LC-MS/MS 
(method B) (Kilcoyne et al., 2012). 
2.5.5. LC-MS/MS analysis 
Method A: The samples were analyzed by LC-MS/MS to quantify AZAs using an HPLC 
(model UFLCxr, Shimadzu) coupled to a triple-quadrupole mass spectrometer (API 4000Qtrap, 
Applied Biosystems). Separation and LC-MS/MS procedures were as described by Jauffrais et 
al. (2012c) and based on a previous study (Rehmann et al., 2008). External calibration against 
AZA1, -2 and -3 were used for quantification using Analyst 1.5 software (Applied Biosystems), 
assuming that all analogues had the same response factor as AZA1, except for AZA2 and -3 for 
which the respective standards were used.  
Toxic Equivalent Factors (TEFs) were also applied to estimate the true toxic potential of mussel 
samples during the experiment. AZA1 TEFs applied were equal to 1.8 and 1.4 for AZA2 and -3, 
respectively (Ofuji et al., 1999). 
Method B: Samples were analyzed on a Waters 2695 LC coupled to a Micromass triple-stage 
quadrupole Ultima instrument operated in multiple reaction monitoring (MRM) mode with the 
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following transitions: AZA1, m/z 842.5654.4 and 842.5672.4; AZA3, 828.5640.4 and 
828.5658.4; AZA17, 872.5640.5 and 872.5658.4. The cone voltage was 60 V and the 
collision voltage was 40 V, the cone and desolvation gas flows were set at 100 and 800 L/h, 
respectively, and the source temperature was 150 °C. 
Binary gradient elution was used, with phase A consisting of water and phase B of 95% 
acetonitrile in water (both containing 2 mM ammonium formate and 50 mM formic acid). 
Chromatography was performed with a Hypersil BDS C8 column (50 × 2.1 mm, 3 µm, with a 
10 × 2.1 mm guard column of the same stationary phase) (Thermo Scientific). The gradient was 
from 30% B to 90% B over 8 min at 0.25 mL.min
-1
, held for 5 min, then held at 100% B at 
0.4 mL.min
-1
 for 5 min, before returning to the initial conditions (4 min hold) to equilibrate the 
system. The injection volume was 5 µL and the column and sample temperatures were 25 °C 
and 6 °C, respectively. 
3. Results and discussion 
Dissolved AZAs as well as other lipophilic toxins were found in water using passive samplers 
on the west coast of Ireland (Fux et al., 2009). This raised questions on the bioavailability of 
dissolved AZAs to shellfish or other aquatic organisms, especially, since other dissolved 
polyether marine biotoxins have been found to accumulate in shellfish (brevetoxin in 
Crassostrea virginica (Plakas et al., 2002)). Unfortunately, the passive sampling method used in 
the first study (Fux et al., 2009) was qualitative and could not estimate actual AZA 
concentrations in sea water. In the present study two levels of cellular concentrations were 




 of A. spinosum 




 of A. spinosum, similar to that 
reported in Argentina (Akselman and Negri, 2012). However, to our knowledge, no data are 
available on the AZA cell quota of A. spinosum in natural blooms. We therefore based these 
experiments on a AZA cell quota obtained from A. spinosum in culture, even though these 
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results are only indicative. Subsequently, the first trial evaluated where AZA uptake or 
accumulation occur, and whether dissolved AZAs released from decaying blooms of A. 
spinosum could be relevant to the shellfish industry and to human health or could play a role in 
ecological interactions with other aquatic organisms. 
Thus, AZA accumulation by mussels was assessed using exposure to A. spinosum cells (live or 
lysed), and to dissolved AZAs (alone or in mixture with non-toxic microalgae) as possible 
routes of contamination. 
In treatments 1–7, LC-MS/MS analyses showed the presence of AZAs in the digestive gland, 
gills and remaining flesh of mussels after 24 h of exposure (Table 2). Treatments 1 and 3–7 
resulted in concentrations of regulated AZAs (255–591 µg kg-1 AZA1eq) above the regulatory 
limit (160 µg kg
-1




resulted in a total 
AZA concentration of 71 µg kg
-1 
AZA1eq. 
These results indicate that AZA accumulation in mussels can occur not only from exposure to 
living A. spinosum cells (Jauffrais et al., 2012c; Salas et al., 2011), but also from exposure to 
dissolved AZAs in the presence or absence of algal cells or cellular debris. To our knowledge, 
this study is the first experiment to quantitatively assess the direct accumulation of dissolved 
AZAs by mussels without any source of food. 
The highest concentrations in mussels were obtained for treatments with the highest 
concentration of AZAs (7.5 µg L
-1
). Exposure to live A. spinosum resulted in higher total AZA 








, respectively) than by other 
routes of exposure to equivalent AZA concentrations (Table 2). 










), all cells were consumed in less than 5 h. Furthermore, mussels exposed to dissolved AZAs 
with T-Iso consumed 3/4 of the available alga (Fig. 1).  
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Note that Isochrysis aff. galbana (CCAP 927/14, T-Iso), is a non-toxic microalga used in 
aquaculture to feed farmed bivalve molluscs (Marchetti et al., 2012). 
Differences in toxin distribution across tissues were observed due to the route of exposure and 
only minor effects due to toxin level (Fig. 2). When AZAs were dissolved, most of the toxin 
was found in gills (42-46%) and remaining flesh (30-35%), whereas the toxin was mainly found 
in the digestive gland when A. spinosum cells (both lysed or living) were the source of the toxin 
(Fig. 2). The AZA distribution in mussels fed live A. spinosum here was similar to that reported 
in a previous similar experiment (73% DG, 8% gills and 19% RF (Jauffrais et al., 2012c)). In 
treatment 3, with dissolved AZA plus non-toxic food, a 2-fold higher concentration of AZA was 
observed in the digestive gland, compared to treatment 1 (without algae), even though the total 
amount accumulated into mussel tissues was virtually identical (Table 2). The same trend is 
observed when examining the percentages of toxin accumulated in digestive gland compared to 
other tissues, with live A. spinosum cells > lysed cells > dissolved plus non-toxic cells > 
dissolved toxins. Partial adsorption of dissolved AZAs onto the algal cells and cellular debris, 
followed by ingestion by the mussels, may be responsible for this phenomenon. 
In addition to the digestive uptake route previously shown (Jauffrais et al., 2012c; Salas et al., 
2011), uptake from the dissolved phase through the gills is a plausible route of accumulation. 
Similar observations have also been made with fish exposed to water soluble toxins 
microcystin-RR (Cazenave et al., 2005) and saxitoxin (Bakke and Horsberg, 2010) but to our 
knowledge no results on accumulation by the gills are reported using only dissolved lipophilic 
toxins. Furthermore, analogue ratios found in the present study suggest that AZA 
transformations in gills are faster than in the digestive gland (Table 2 and Fig. 3). However, no 
data is available on transfer of AZAs across mussel tissues. Consequently, further studies using 
different organisms, e.g. fish, could help to confirm whether AZA uptake through the gills 
during ventilation and filtration processes leads to systemic distribution of AZAs. 
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A similar experiment was performed to study AZA biotransformation in mussels, however, 
mussels were exposed to dissolved AZAs in combination with a non-toxic microalgal diet 
(O'Driscoll et al., 2011). These authors observed larger AZA accumulation in gills and 
remaining tissues than in digestive glands; however, it is difficult to compare further due to the 
absence of quantitative data and differences in experimental design. Also, these authors found 
an unusual toxin profile (i.e. a large amount of AZA3), compared to the literature (Fux et al., 
2009; Jauffrais et al., 2012c; McCarron et al., 2009; Salas et al., 2011). In most cases, toxin 
profiles found in the present experiment contained AZA1–3, AZA7, 8, -17 and -19 (Table 2, 
Fig. 4), and for all tissues AZA3, -7, -8 and -19 represented less than 20% of the total AZAs. 
The toxin profile was also found to be different in different mussel organs (table 2 and Fig. 3). 
For all treatments, the digestive gland always had AZA1 and -2 as the major AZAs (together 
>75%), whereas in the gills and remaining flesh the main AZAs were AZA1 and -17, with the 
proportion of AZA17 often greater than or comparable to that of AZA1 (Fig. 3). Furthermore, 
the gills and the remaining flesh always showed a higher proportion of metabolites of AZA1 
and -2 than the digestive glands. This is in accord with previous results from mussels fed A. 
spinosum (Jauffrais et al., 2012c), and raised questions about the role of the different mussel 
tissues in AZA biotransformation. 
 
The second objective was to evaluate the feasibility of preparative production of AZA 
metabolites using mussels exposed to dissolved semi-purified AZA1. The AZA mass balance of 
this experiment (Table 3) showed an overall AZA recovery of 60%, with AZA1 accounting for 
37%, AZA17 for 19% and AZA3 for 4%. AZAs found in mussels after four days of exposure to 
AZA1 represented 29% of the administered toxin, with AZA17 comprising the biggest 
proportion. Only 17% of the original AZA1 sample was converted to AZA17 which, combined 
with the fact that the mussels have a limited ability to accumulate AZAs under such conditions, 
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would render this impractical as a means of producing sufficiently contaminated material for 
isolation purposes. Additionally, a significant proportion (40%) of toxin was not accounted for, 
suggesting additional, unknown, transformation processes occurring within shellfish or in 
seawater. After 4 days of exposure, low levels (~ 2% of the original AZA1 added to the tank) 
of both AZA17 and AZA3 were detectable in the seawater, suggesting that these toxins can be 
excreted by the shellfish, and transported into the surrounding aqueous environments. 
5. Conclusions 
The present study shows that dissolved AZAs were bioavailable for mussels and that AZA 
accumulation may reach concentrations above the regulatory limit and thus might be considered 
as a food safety issue. However, differences observed in the distribution of toxins in the 
shellfish which depended on whether the shellfish were exposed to dissolved AZAs or to live or 
lysed A. spinosum. This finding tended to decrease the importance of dissolved AZAs as a 
source of contamination relevant for human health as the AZA distribution found in situ reflect 
results observed with live A. spinosum. This different AZA distribution between tissues 
indicates that AZA uptake can occur in the digestive gland during feeding and also through the 
gills during respiratory and filtration activities in the presence of dissolved AZAs. This last 
observation raises questions as to the mechanisms involved in the uptake of AZAs through the 
gills and about the potential for subsequent re-distribution to other organs. The bioavailability of 
dissolved AZAs shown for mussels also raises questions regards possible effects on other 
aquatic organisms. The second trial on the preparative production of AZA metabolites by 
mussel exposure to semi-purified AZA1 resulted in formation of AZA1 metabolites in mussels, 
but the conversion efficiency and the recovery was too low to justify using this procedure for 
preparative isolation. Hence, further studies should investigate these losses and the existence of 
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